The 20 Best Acute Myeloblastic Leukemia without Maturation Doctors Near Me in Newport Beach, CA

Elias Kiwan is an Oncologist practicing medicine in Sacramento, California. Dr. Kiwan is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 77 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kiwan is board certified in Medical Oncology - Board Certified , Hematology - Board Certified , and Not ABMS Specialty. Dr. Kiwan is currently accepting new patients.

Stephen Forman is a Hematologist and an Oncologist practicing medicine in Duarte, California. Dr. Forman is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Gary Schiller is an Oncologist practicing medicine in Los Angeles, California. Dr. Schiller is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Deepa Jeyakumar is a board-certified UCI Health hematologist-oncologist who specializes in the diagnosis and treatment of blood cancers, bone marrow transplantation and stem-cell therapy. Her clinical focus is on treating patients with leukemias, lymphomas, myelodysplastic syndromes and myelomas.Jeyakumar earned her medical degree at Temple University’s Lewis Katz School of Medicine in Philadelphia, PA. She completed a residency in internal medicine at the University of Illinois Medical Center in Chicago, followed by a fellowships in hematology/oncology at Tufts Medical Center in Boston, Mass., and bone marrow transplantation at Stanford University in Palo Alto, Calif.She is the author or co-author of numerous publications, posters and abstracts, as well as a chapter on acute myelogenous leukemia in a leading book on care for cancer survivors. Dr. Jeyakumar is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic T-Cell Leukemia (CTCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jeyakumar is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Wen-kai Weng is an Oncologist practicing medicine in Stanford, California. Dr. Weng is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Graft Versus Host Disease (GvHD), Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant.

Michaela Liedtke is a Hematologist practicing medicine in Palo Alto, California. Dr. Liedtke is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Primary Amyloidosis, Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Ryotaro Nakamura is an Oncologist practicing medicine in Duarte, California. Dr. Nakamura is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Kiran Naqvi is a board-certified UCI Health hematologic oncologist. Her clinical focus is on acute myeloid leukemia, myelodysplastic syndrome, chronic myelogenous leukemia, bone marrow aspiration and bone marrow transplantation.She earned her medical degree from Dow University of Health Sciences in Karachi, Pakistan. She completed a residency in internal medicine at the University of Illinois Urbana-Champaign and the Carle Foundation Hospital in Urbana, Ill., followed by fellowships in hematology-oncology at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center, both in Houston, Texas. Dr. Naqvi is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), Leukemia, and Bone Marrow Aspiration. Dr. Naqvi is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Andrew Rezvani is an Oncologist practicing medicine in Palo Alto, California. Dr. Rezvani is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Colonoscopy.

Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Martin is board certified in American Board Of Internal Medicine, Hematology. Dr. Martin is currently accepting new patients.

Robert Negrin is a Hematologist practicing medicine in Stanford, California. Dr. Negrin is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant.

Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sayre is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Sayre is currently accepting new patients.

Dr. Catherine Smith is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis. Smith's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients. A San Francisco native, Smith earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Essential Thrombocythemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Bone Marrow Aspiration. Dr. Smith is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Smith is currently accepting new patients.

Oleg Krijanovski is a Hematologist practicing medicine in Berkeley, California. Dr. Krijanovski is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Krijanovski is currently accepting new patients.

Xin Li is a Hematologist practicing medicine in Berkeley, California. Dr. Li is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Li is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Li is currently accepting new patients.

Caspian Oliai is a Hematologist practicing medicine in Los Angeles, California. Dr. Oliai is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Oliai is board certified in Internal Medicine, Internal Medicine (Sub: Hematology), and Internal Medicine (Sub: Medical Oncology). Dr. Oliai is currently accepting new patients.

Anthony Stein is an Oncologist practicing medicine in Duarte, California. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ahmed Aribi is a Hematologist practicing medicine in Duarte, California. Dr. Aribi is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.